Literature DB >> 24899717

Presynaptic calcium channel inhibition underlies CB₁ cannabinoid receptor-mediated suppression of GABA release.

Gergely G Szabó1, Nora Lenkey2, Noemi Holderith2, Tibor Andrási1, Zoltan Nusser3, Norbert Hájos4.   

Abstract

CB1 cannabinoid receptors (CB1) are located at axon terminals and effectively control synaptic communication and thereby circuit operation widespread in the CNS. Although it is partially uncovered how CB1 activation leads to the reduction of synaptic excitation, the mechanisms of the decrease of GABA release upon activation of these cannabinoid receptors remain elusive. To determine the mechanisms underlying the suppression of synaptic transmission by CB1 at GABAergic synapses, we recorded unitary IPSCs (uIPSCs) at cholecystokinin-expressing interneuron-pyramidal cell connections and imaged presynaptic [Ca(2+)] transients in mouse hippocampal slices. Our results reveal a power function with an exponent of 2.2 between the amplitude of uIPSCs and intrabouton [Ca(2+)]. Altering CB1 function by either increasing endocannabinoid production or removing its tonic activity allowed us to demonstrate that CB1 controls GABA release by inhibiting Ca(2+) entry into presynaptic axon terminals via N-type (Cav2.2) Ca(2+) channels. These results provide evidence for modulation of intrabouton Ca(2+) influx into GABAergic axon terminals by CB1, leading to the effective suppression of synaptic inhibition.
Copyright © 2014 the authors 0270-6474/14/347958-06$15.00/0.

Entities:  

Keywords:  GABAergic interneuron; endocannabinoid; hippocampus; mouse

Mesh:

Substances:

Year:  2014        PMID: 24899717      PMCID: PMC6608264          DOI: 10.1523/JNEUROSCI.0247-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons.

Authors:  Önder Albayram; Stefan Passlick; Andras Bilkei-Gorzo; Andreas Zimmer; Christian Steinhäuser
Journal:  Pflugers Arch       Date:  2016-01-07       Impact factor: 3.657

Review 2.  Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System.

Authors:  Shana M Augustin; David M Lovinger
Journal:  ACS Chem Neurosci       Date:  2018-02-19       Impact factor: 4.418

Review 3.  Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning.

Authors:  György Buzsáki
Journal:  Hippocampus       Date:  2015-10       Impact factor: 3.899

4.  Target Cell Type-Dependent Differences in Ca2+ Channel Function Underlie Distinct Release Probabilities at Hippocampal Glutamatergic Terminals.

Authors:  Tímea Éltes; Tekla Kirizs; Zoltan Nusser; Noemi Holderith
Journal:  J Neurosci       Date:  2017-01-23       Impact factor: 6.167

5.  Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol.

Authors:  Benjamin A Harlan; Howard C Becker; John J Woodward; Arthur C Riegel
Journal:  Neuropsychopharmacology       Date:  2018-06-09       Impact factor: 7.853

Review 6.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

7.  Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.

Authors:  Maria do Carmo Costa; Naila S Ashraf; Svetlana Fischer; Yemen Yang; Emily Schapka; Gnanada Joshi; Thomas J McQuade; Rahil M Dharia; Mark Dulchavsky; Michelle Ouyang; David Cook; Duxin Sun; Martha J Larsen; Jason E Gestwicki; Sokol V Todi; Magdalena I Ivanova; Henry L Paulson
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

8.  BDNF-induced endocannabinoid release modulates neocortical glutamatergic neurotransmission.

Authors:  Mason L Yeh; Rajamani Selvam; Eric S Levine
Journal:  Synapse       Date:  2017-02-11       Impact factor: 2.562

Review 9.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

10.  β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.

Authors:  Garret R Anderson; Jason Aoto; Katsuhiko Tabuchi; Csaba Földy; Jason Covy; Ada Xin Yee; Dick Wu; Sung-Jin Lee; Lu Chen; Robert C Malenka; Thomas C Südhof
Journal:  Cell       Date:  2015-07-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.